NuGen Announces Partnership with EziAutoJector Limited for Distribution of InsuJet Devices
10/25/24, 9:28 PM
Location
torontoMoney
$645,000
Industry
manufacturing
Type
partnership
NuGen Medical Devices Inc. announced a strategic partnership with EziAutoJector Limited for the delivery of U-100 insulin to individuals with diabetes and subcutaneous biosimilar products using NuGen's InsuJetTM device and consumables. EziAutoJector will promote and open up new opportunities for needle-free subcutaneous medicines and devices in the UK and Germany.
Company Info
Location
18 king street east, suite 1400
toronto, ontario, canada
Additional Info
NuGen is a leading developer of needle-free devices to administer therapeutics subcutaneously. The Company is marketing and selling its next-generation InsuJet™ needle-free injection system designed to improve the lives of millions of diabetics. InsuJet™ is approved for sale in 42 countries around the world.